dextroamphetamine has been researched along with Catatonic Rigidity in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carey, RJ | 1 |
| Maxwell, DR | 1 |
| Read, MA | 1 |
| Sumpter, EA | 1 |
2 other studies available for dextroamphetamine and Catatonic Rigidity
| Article | Year |
|---|---|
Differential effects of limbic versus striatal dopamine loss on motoric function.
Topics: Animals; Catalepsy; Corpus Striatum; Dextroamphetamine; Dopamine; Humans; Hydroxydopamines; Limbic S | 1983 |
Pharmacology of M & B 18,706, a drug which selectively reduces decerebrate rigidity.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Cats; Cerebellar Ataxia; Cerebellum; Chlorpromaz | 1974 |